Publications by authors named "Zied Abdullaev"

18Publications

The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.

Mod Pathol 2020 Sep 14. Epub 2020 Sep 14.

Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-00673-xDOI Listing
September 2020

Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.

Acta Neuropathol Commun 2020 03 20;8(1):37. Epub 2020 Mar 20.

Laboratory of Brain Tumor Metabolism and Epigenetics, Department of Pathology, University of Michigan, 3520E MSRB 1, 1150 W. Medical Center, Ann Arbor, MI, 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40478-020-00905-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083001PMC
March 2020

Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.

J Thorac Oncol 2020 03 26;15(3):457-461. Epub 2019 Nov 26.

Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.11.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044061PMC
March 2020

Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.

Am J Dermatopathol 2019 Mar;41(3):167-179

Associate Professor, Dermatopathology Section, Departments of Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000001217DOI Listing
March 2019

Melanoma in patients with GATA2 deficiency.

Pigment Cell Melanoma Res 2018 03 10;31(2):337-340. Epub 2017 Dec 10.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809272PMC
March 2018

CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.

Clin Cancer Res 2015 Nov 25;21(21):4947-59. Epub 2015 Mar 25.

Cancer Molecular Pathology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583342PMC
November 2015

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

J Clin Oncol 2015 Mar 9;33(9):1000-7. Epub 2015 Feb 9.

Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher C. Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Eva Szabo, Yisong Wang, and Giuseppe Giaccone, National Cancer Institute; Austin Doyle, Cancer Therapy Evaluation Program, Bethesda, MD; Ariel Lopez-Chavez, Christopher L. Corless, Alan Sandler, Carol Beadling, and Andrea Warrick, Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Ariel Lopez-Chavez, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Yisong Wang and Giuseppe Giaccone, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.2007
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.2007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356709PMC
March 2015

Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion.

Virchows Arch 2014 Aug 4;465(2):233-9. Epub 2014 Jul 4.

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-014-1613-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314183PMC
August 2014

Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

J Thorac Oncol 2014 Apr;9(4):567-71

*Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; †Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and ‡Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705182PMC
April 2014

ER/PR positive epidermotropic primary cutaneous eccrine carcinoma as a cutaneous manifestation of MEN 2B.

J Am Acad Dermatol 2013 Dec;69(6):e310-2

Dermatopathology Section, Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561254PMC
December 2013